Abstract

Hallucinations are a core feature of psychosis and common in Parkinson’s. Their transient, unexpected nature suggests a change in dynamic brain states, but underlying causes are unknown. Here, we examine temporal dynamics and underlying structural connectivity in Parkinson’s-hallucinations using a combination of functional and structural MRI, network control theory, neurotransmitter density and genetic analyses. We show that Parkinson’s-hallucinators spent more time in a predominantly Segregated functional state with fewer between-state transitions. The transition from integrated-to-segregated state had lower energy cost in Parkinson’s-hallucinators; and was therefore potentially preferable. The regional energy needed for this transition was correlated with regional neurotransmitter density and gene expression for serotoninergic, GABAergic, noradrenergic and cholinergic, but not dopaminergic, receptors. We show how the combination of neurochemistry and brain structure jointly shape functional brain dynamics leading to hallucinations and highlight potential therapeutic targets by linking these changes to neurotransmitter systems involved in early sensory and complex visual processing.

The examination of temporal dynamics in Parkinson’s-hallucinations reveals that the combination of neurochemistry and brain structure jointly shape functional brain dynamics leading to hallucinations.

Details

Title
Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease
Author
Zarkali, Angeliki 1   VIAFID ORCID Logo  ; Luppi, Andrea I. 2   VIAFID ORCID Logo  ; Stamatakis, Emmanuel A. 2   VIAFID ORCID Logo  ; Reeves, Suzanne 3 ; McColgan, Peter 4 ; Leyland, Louise-Ann 1 ; Lees, Andrew J. 5 ; Weil, Rimona S. 6 

 University College London, Dementia Research Centre, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201) 
 University of Cambridge, Division of Anaesthesia, School of Clinical Medicine, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge, Department of Clinical Neurosciences, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
 University College London, Division of Psychiatry, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201) 
 University College London, Huntington’s Disease Centre, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201) 
 University College London, Reta Lila Weston Institute of Neurological Studies, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201) 
 University College London, Dementia Research Centre, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); University College London, Wellcome Centre for Human Neuroimaging, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); University College London, Movement Disorders Consortium, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2711649997
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.